Updated On: 25 June, 2022 12:34 PM IST | New Delhi | IANS
The Subject Expert Committee of Drugs Controller General Of India has recommended Serum Institute of India’s (SII) vaccine Covovax for children in the age group of 7-11 years

Representational image. Pic/iStock
Drugs Controller General of (DCGI) India on Friday recommended Emergency Use Authorisation (EUA) for Serum Institute of India’s Covovax vaccine for children aged 7-11, a source on Friday.
“The Subject Expert Committee of Drugs Controller General Of India has recommended Serum Institute of India’s (SII) vaccine Covovax for children in the age group of 7-11 years,” said the source.